About
Liliumtx develops precision in vivo gene therapies that selectively target pathogenic T cells to treat autoimmune diseases and oncology, using engineered delivery vehicles to enable safe and specific immune reprogramming.
Explore Liliumtx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.